CommercialCoverageMedium impact
08.01.05m, Carfilzomib (Kyprolis®)
Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Nov 17, 2025
We identified it
Jun 19, 2026
Summary
Carfilzomib (Kyprolis®) policy updated with new medical necessity criteria and medical coding requirements for commercial plans. This affects billing and coverage determinations for this cancer medication effective November 17, 2025.
Action Required
By November 17, 2025: Clinical and billing teams must review updated medical necessity criteria for Carfilzomib (Kyprolis®) prescriptions. Update prior authorization documentation requirements in pharmacy benefit management system. Ensure all future claims meet new medical coding and necessity criteria to prevent denials.